Australia: Patentability of isolated DNA

The following is an excerpt.

Patents on human genes continue to cause controversy in the academic and popular press. A recent decision  in Australia (1) has reaffirmed the patentability of isolated human DNA in that jurisdiction, reigniting the debate on the appropriateness of such patents and their potential to negatively affect access to healthcare.

Following the race to identify and isolate genes associated with hereditary breast cancer, patents associated with the BRCA1 and BRCA2 genes were granted in a number of jurisdictions. These patents are controlled byMyriad Genetics , which has pursued a business of model of monopoly for the provision of genetic tests for breast cancer, preventing a broader range of providers from offering the test.

View the original article here: Patentability of isolated DNA in the Australian context: Cancer Voices Australia vs Myriad Genetics Inc

Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Infographic: What are mRNA COVID-19 vaccines and how do they work?

Infographic: What are mRNA COVID-19 vaccines and how do they work?

As of 1 December 2020, thirteen vaccines have reached the final stage of testing: where they are being given to ...

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend